BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5972038)

  • 1. N-methyl-n-2-propynyl-l-indanamine. A protent monoamine oxidase inhibitor.
    Huebner CF; Donoghue EM; Plummer AJ; Furness PA
    J Med Chem; 1966 Nov; 9(6):830-2. PubMed ID: 5972038
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B.
    Heikkila RE; Duvoisin RC; Finberg JP; Youdim MB
    Eur J Pharmacol; 1985 Oct; 116(3):313-7. PubMed ID: 3935467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazolecarboxhydrazides. I. Chemistry and biological evaluation.
    Nematollahi J; Guess W; Autian J
    J Med Chem; 1966 Sep; 9(5):660-4. PubMed ID: 5969034
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    MaƮtre L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 5. The inhibition of rat brain monoamine oxidase-B by J-508 (N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride), and its use for the titration of this enzyme form.
    Fowler CJ; Oreland L; Wiberg A; Carlsson A; Magnusson T
    Med Biol; 1979; 57(6):406-11. PubMed ID: 547123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective monoamine oxidase inhibitor drugs as aids in evaluating the role of type A and B enzymes.
    Fuentes JA; Neff NH
    Neuropharmacology; 1975 Nov; 14(11):819-25. PubMed ID: 1207877
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and pharmacology of a pargyline analog, N-3-(1-butynyl)-benzylamine.
    Siuda JF; Cihonski C; Sofia RD; Buckley JP
    J Pharm Sci; 1973 Feb; 62(2):331-2. PubMed ID: 4686418
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of insulin release by substrates and inhibitors of monoamine oxidase.
    Aleyassine H; Lee SH
    Am J Physiol; 1972 Mar; 222(3):565-9. PubMed ID: 5022664
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):12-8. PubMed ID: 4269286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-cyclopropyltryptamines, potent monoamine oxidase inhibitors.
    Winn M; Horrom BW; Rasmussen RR; Chappell EB; Plotnikoff NP
    J Med Chem; 1975 Apr; 18(4):437-8. PubMed ID: 1079054
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of monoamine oxidase inhibitors of various chemical nature on some indices of carbohydrate metabolism in the rabbit brain].
    Musialkovskaia AA
    Ukr Biokhim Zh; 1967; 39(2):119-24. PubMed ID: 5603054
    [No Abstract]   [Full Text] [Related]  

  • 13. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioural studies of the actions of cocaine, monoamine oxidase inhibitors and iminodibenzyl compounds on central dopamine neurones.
    Christie JE; Crow TJ
    Br J Pharmacol; 1973 Jan; 47(1):39-47. PubMed ID: 4577590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some indole and benzo[b]thiophene derivatives. Synthesis and pharmacology.
    Chapman NB; Clarke K; Iddon B
    J Med Chem; 1966 Nov; 9(6):819-23. PubMed ID: 5972036
    [No Abstract]   [Full Text] [Related]  

  • 17. The degeneration contraction of a sympathetically innervated smooth muscle in the rat after reserpine, inhibition of monoamine oxidase or tyrosine hydroxylase.
    Lundberg D
    Acta Physiol Scand; 1970 Sep; 80(1):107-16. PubMed ID: 4394456
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of reserpine and monoamine oxidase inhibition on the levels of amino acids in sensory ganglia, sympathetic ganglia and spinal cord.
    Santini M; Berl S
    Brain Res; 1972 Nov; 47(1):167-76. PubMed ID: 4641266
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonism of reserpine-induced emesis in pigeons: a screening method for antidepressant activity.
    Dhawan KN; Gupta GP; Jaju BP
    Br J Pharmacol; 1968 Oct; 34(2):248-50. PubMed ID: 5687584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic antidepressives--a possible mode of action.
    Offermeier J; Potgieter B
    S Afr Med J; 1969 Nov; 43(45):1366-70. PubMed ID: 5358038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.